Literature DB >> 27620391

c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II-Induced Hypertension.

Glaucia E Callera1, Tayze T Antunes1, Ying He1, Augusto C Montezano1, Alvaro Yogi1, Carmine Savoia1, Rhian M Touyz2.   

Abstract

c-Src plays an important role in angiotensin II (Ang II) signaling. Whether this member of the Src family kinases is involved in the development of Ang II-induced hypertension and associated cardiovascular damage in vivo remains unknown. Here, we studied Ang II-infused (400 ng/kg/min) mice in which c-Src was partially deleted (c-Src+/-) and in wild-type (WT, c-Src+/+) mice treated with a c-Src inhibitor (CGP077675; 25 mg/kg/d). Ang II increased blood pressure and induced endothelial dysfunction in WT mice, responses that were ameliorated in c-Src+/- and CGP077675-treated mice. Vascular wall thickness and cross-sectional area were similarly increased by Ang II in WT and c-Src+/- mice. CGP077675 further increased cross-sectional area in hypertensive mice. Cardiac dysfunction (ejection fraction and fractional shortening) in Ang II-infused WT mice was normalized in c-Src+/- mice. Increased oxidative stress (plasma thiobarbituric acid-reactive substances, hydrogen peroxide, and vascular superoxide generation) in Ang II-infused WT mice was attenuated in c-Src-deficient and CGP077675-treated mice. Hyperactivation of vascular c-Src, ERK1/2 (extracellular signal-regulated kinase 1/2), and JNK (c-Jun N-terminal kinase) in hypertensive mice was normalized in CGP077675-treated and c-Src+/- mice. Vascular fibronectin was increased by Ang II in all groups and further augmented by CGP077675. Cardiac fibrosis and inflammation induced by Ang II were amplified in c-Src+/- and CGP-treated mice. Our data indicate that although c-Src downregulation attenuates development of hypertension, improves endothelial and cardiac function, reduces oxidative stress, and normalizes vascular signaling, it has little beneficial effect on fibrosis. These findings suggest a divergent role for c-Src in Ang II-dependent hypertension, where c-Src may be more important in regulating redox-sensitive cardiac and vascular function than fibrosis and remodeling.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin II; arteries; hypertension; oxidative stress; phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27620391     DOI: 10.1161/HYPERTENSIONAHA.116.07699

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

Review 2.  AT1 receptor signaling pathways in the cardiovascular system.

Authors:  Tatsuo Kawai; Steven J Forrester; Shannon O'Brien; Ariele Baggett; Victor Rizzo; Satoru Eguchi
Journal:  Pharmacol Res       Date:  2017-05-17       Impact factor: 7.658

Review 3.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.

Authors:  Karla B Neves; Adam P Harvey; Fiona Moreton; Augusto C Montezano; Francisco J Rios; Rhéure Alves-Lopes; Aurelie Nguyen Dinh Cat; Paul Rocchicciolli; Christian Delles; Anne Joutel; Keith Muir; Rhian M Touyz
Journal:  JCI Insight       Date:  2019-12-05

Review 5.  Vascular smooth muscle contraction in hypertension.

Authors:  Rhian M Touyz; Rheure Alves-Lopes; Francisco J Rios; Livia L Camargo; Aikaterini Anagnostopoulou; Anders Arner; Augusto C Montezano
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

6.  The Orphan Receptor GPR35 Contributes to Angiotensin II-Induced Hypertension and Cardiac Dysfunction in Mice.

Authors:  Nina Divorty; Graeme Milligan; Delyth Graham; Stuart A Nicklin
Journal:  Am J Hypertens       Date:  2018-08-03       Impact factor: 2.689

7.  NADPH Oxidase 5 Is a Pro-Contractile Nox Isoform and a Point of Cross-Talk for Calcium and Redox Signaling-Implications in Vascular Function.

Authors:  Augusto C Montezano; Livia De Lucca Camargo; Patrik Persson; Francisco J Rios; Adam P Harvey; Aikaterini Anagnostopoulou; Roberto Palacios; Ana Caroline P Gandara; Rheure Alves-Lopes; Karla B Neves; Maria Dulak-Lis; Chet E Holterman; Pedro Lagerblad de Oliveira; Delyth Graham; Christopher Kennedy; Rhian M Touyz
Journal:  J Am Heart Assoc       Date:  2018-06-15       Impact factor: 5.501

8.  Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)).

Authors:  Li Lu; Li Cao; Yihao Liu; Yunlin Chen; Jinqi Fan; Yuehui Yin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension.

Authors:  Livia L Camargo; Augusto C Montezano; Misbah Hussain; Yu Wang; Zhiguo Zou; Francisco J Rios; Karla B Neves; Rheure Alves-Lopes; Fazli R Awan; Tomasz J Guzik; Thomas Jensen; Richard C Hartley; Rhian M Touyz
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 10.787

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.